MBHB Partner Kevin Noonan Quoted in BioWorld Article Entitled, “Generics and Teva position themselves for Copaxone win”

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in an April 16, 2014 edition of BioWorld in an article entitled, “Generics and Teva position themselves for Copaxone win.”  View the article (subscription required)

Search
Menu
Menu